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Abstract
Objectives—We tested the efficacy of an adapted evidence-based HIV–sexually transmitted 
infection (STI) behavioral intervention (Providing Opportunities for Women′s Empowerment, 
Risk-Reduction, and Relationships, or POWER) among incarcerated women.
Methods—We conducted a randomized trial with 521 women aged 18 to 60 years in 2 
correctional facilities in North Carolina in 2010 and 2011. Intervention participants attended 8 
POWER sessions; control participants received a single standard-of-care STI prevention session. 
We followed up at 3 and 6 months after release. We examined intervention efficacy with mixed-
effects models.
Results—POWER participants reported fewer male sexual partners than did control participants 
at 3 months, although this finding did not reach statistical significance; at 6 months they reported 
significantly less vaginal intercourse without a condom outside of a monogamous relationship and 
more condom use with a main male partner. POWER participants also reported significantly fewer 
condom barriers, and greater HIV knowledge, health-protective communication, and tangible 
social support. The intervention had no significant effects on incident STIs.
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Conclusions—POWER is a behavioral intervention with potential to reduce risk of acquiring or 
transmitting HIV and STIs among incarcerated women returning to their communities.
Women accounted for 20.8% of all US adults and adolescents diagnosed with HIV in 2011.1 
Women’s risk of HIV infection is attributable to a confluence of factors, including 
unprotected vaginal and anal intercourse, injection drug or substance use, lack of awareness 
of sexual partners’ risk behaviors, sexual abuse and violence, and a history of sexually 
transmitted infections (STIs).2
Incarcerated women experience high rates of HIV and STIs.3–5 In 2010, 1.9% of 
incarcerated adult women were HIV positive. This rate of HIV infection was nearly 13 times 
as high as among the general population of adult women (0.15%) in the United States.6 In 
2010, the rates of gonorrhea and chlamydia among adult incarcerated women were 1.9% and 
6.9%, respectively; these were the highest rates observed among women in any venue.7 
Furthermore, an estimated 22 723 HIV-infected women in the United States are released 
from a correctional facility annually, suggesting an important opportunity for HIV–STI 
prevention.8 The HIV–STI risk reduction needs of incarcerated women are complex because 
of myriad factors, including high levels of mental health issues; illicit substance use; poor 
social support systems; history of sex work; previous and current physical, sexual, and 
emotional abuse from male partners; and issues pertaining to prison release and reentry into 
communities of origin.9–15 Community reentry is a vulnerable time for women and is 
associated with increases in sexual risk, substance use, and recidivism.16
The risk profile of incarcerated women indicates that prisons and jails are important settings 
for prevention interventions that can be delivered in a relatively short time.17 However, 
HIV–STI prevention interventions delivered to women in prisons and jails are limited.18–20 
Despite incarcerated women’s significant level of risk, no efficacious behavioral HIV–STI 
risk reduction interventions target them and facilitate their transition from prisons to 
communities.21
To address this critical gap, we adapted an existing evidence-based HIV–STI prevention 
intervention, SAFE (Sexual Awareness for Everyone), for incarcerated women.22 SAFE is a 
small-group motivational and skills-building intervention shown to be efficacious in 
reducing risky sexual behaviors and incident nonviral STIs among minority women 
diagnosed with STIs in public health clinics.23,24 We selected SAFE for adaptation because 
the intervention addresses prevention themes relevant for women prisoners, including 
awareness of personal risk, sexual behavior risk reduction, reduction in numbers of partners, 
and acquisition of skills such as communication with sexual partners.22 We followed a 
systematic adaptation process25 in creating Providing Opportunities for Women’s 
Empowerment, Risk-Reduction, and Relationships (POWER) to address the sexual risk 
reduction needs of women in prison.22 We incorporated themes not specifically addressed 
by SAFE, such as the role of substance abuse in HIV risk, implications of sex work as a risk 
behavior, impact of violence on risk reduction efforts, and barriers to incorporating risk 
reduction upon community reentry.22
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Our study was part of the Adopting and Demonstrating the Adaptation of Prevention 
Techniques (ADAPT-2) project, which systematically adapts and tests the efficacy of 
evidence-based HIV behavioral interventions for populations at highest risk of HIV 
acquisition or transmission.26 We assessed the efficacy of POWER to reduce incident 
nonviral STIs and sexual risk behaviors and increase risk reduction practices among women 
in 2 correctional facilities in North Carolina.
METHODS
Recruitment and enrollment took place between September 2010 and November 2011 in the 
North Carolina Correctional Institute for Women in Raleigh and the Fountain Correctional 
Center for Women in Rocky Mount. The North Carolina Correctional Institute for Women is 
the state’s primary processing facility and largest women’s prison; it houses more than 1100 
inmates. Fountain Correctional Center for Women is a minimum security prison housing 
more than 500 inmates. All women enter the larger facility and are tested for STIs, including 
HIV, during intake. Women who test positive for an STI are treated prior to assignment to a 
specific prison. All HIV-infected women are linked to care and treatment.
We identified newly incarcerated women in the North Carolina Department of Corrections 
(NCDOC) database who had a sentence length of 12 months or less. Prison staff reviewed 
the names and excluded women with documented symptoms of acute psychosis. Eligibility 
criteria were speaking English, being 18 years or older, being able to provide verbal and 
written consent, planning to live in North Carolina for the length of the study, having had or 
expecting to have sexual activity with a man, being HIV negative, and having less than 6 
months to serve. Among 820 women screened, 172 refused to participate, 106 did not meet 
eligibility criteria, 16 were transferred to a nonparticipating prison, 3 initially expressed 
interest but dropped out prior to randomization, and 2 were removed at the prison’s request 
(Figure A, available as a supplement to the online version of this article at http://
www.ajph.org). The final sample comprised 521 women.
Prior to the start of the study, we generated a randomization sequence and placed each 
participant’s assignment in a sealed opaque envelope. This allowed the interviewer to 
remain blinded during the baseline assessment. After we obtained written and signed 
informed consent from each study participant, we conducted a baseline interview in a 
private room without prison staff present. We read all questions (and those for subsequent 
interviews) to the participants with the aid of audio computer-assisted self-interviewing 
software to increase comprehension for women with low literacy. After the interview, the 
interviewer opened the envelope and described the participant’s assignment to either the 
POWER (n = 265) or control (n = 256) study arm. We collected follow-up data 3 and 6 
months after release from prison. We conducted post-release interviews in private settings of 
participants’ choosing, such as their home or a fast food restaurant.
Women received snacks during the POWER sessions. Because NCDOC regulations prohibit 
provision of money or other tangible reimbursements to incarcerated persons, we mailed a 
cosmetic case containing condoms, lubricant, and body lotion to all study participants after 
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their release. All study participants received a total of $60 ($30 per interview) for 
completing the 3- and 6-month postrelease interviews.
Interventions
Formative research to adapt SAFE for women prisoners is described elsewhere.22,27 Briefly, 
we conducted semistructured interviews with 25 newly incarcerated and 28 formerly 
incarcerated women to explore how individual, interpersonal, and societal factors contribute 
to sexual risk behavior before incarceration and after release.28 We also discussed women’s 
ideas regarding factors that influence risky behaviors and recommendations for risk 
reduction interventions for incarcerated women. For example, women identified the 
importance of receiving mentoring from previously incarcerated peers; however, 
opportunities for in-person peer mentoring are limited by prison policies restricting access to 
inmates. To address this restriction, we developed 8 video segments of 4 to 5 minutes from 
interviews with formerly incarcerated women and interspersed them throughout the POWER 
sessions to convey information, inspire participants, and prompt discussion.22
The AIDS Risk Reduction Model provided the theoretical basis for SAFE, and POWER 
incorporates the 3 main stages of the model: (1) recognizing one’s risk, (2) commitment to 
reducing that risk, and (3) following through with the commitment by seeking solutions.29 
POWER addresses stage-specific needs and includes knowledge of disease transmission, 
recognition of personal risk, perception of the costs and benefits of behavioral change, self-
efficacy, and attainment of skills.
A nurse and a social worker facilitated POWER in the 2 prisons. We developed a POWER 
training manual (available from C. I. F.) to guide intervention delivery and ensure fidelity to 
the curriculum. All facilitators were female, had advanced training in health education, and 
served as an assistant facilitator 1 time prior to leading their own intervention sessions. 
Facilitators also completed a mandatory training session with NCDOC personnel, which 
addressed prison rules, regulations, appropriate dress and behavior while in the prison, and 
how to address self-reported sexual assault.
POWER consists of 8 interactive group sessions lasting 1.5 hours, delivered over 4 weeks.22 
The content of the first 6 sessions is similar to SAFE, and the last 2 sessions are tailored to 
incarcerated women. Session 1 introduces the purpose of the intervention, presents the facts 
of HIV–STIs for women in general and women prisoners specifically, and dispels myths 
about assessing personal risk. Session 2 introduces the importance of self-protection, 
individual strength, and ability to care for oneself; examines behaviors that place one at risk; 
and presents specific signs and symptoms of HIV and STIs, including graphic pictures of 
disease manifestations. Session 3 focuses on substance abuse; HIV–STI prevention 
practices; partner information; specifics of condoms, including how to use male and female 
versions; and cleaning drug paraphernalia.
Session 4 explores female sexuality and sexual roles for women, what women need and 
want in a relationship, and sexual decision-making. Session 5 discusses male–female 
interaction and relationships, including sexual communication role playing and identifying 
triggers to unsafe sex. Session 6 explores violence, particularly intimate partner violence, 
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and depression as risk factors and teaches strategies for decreasing risk. Session 7 focuses on 
preparing for reentry, going home, setting goals, identifying and contacting a support 
person, and finding out where resources can be obtained after release. Session 8 reviews 
condom negotiation and use, including role-playing specific situations; issues to negotiate 
before going home; and setting goals for oneself. This session also includes a graduation 
ceremony.
POWER includes a booster session delivered 1 month after session 8 and prior to release; 
the time to release varied in our study. The booster session reviews what was learned during 
previous sessions and helps women prepare for reentry into the community, including 
completing job applications. Three 5-minute booster phone calls were delivered after 
release. During each phone call we reviewed women’s sexual health and reentry plans, 
provided referrals to requested services, and checked on risk reduction efforts, including 
condom use. The phone calls occurred, on average, 21, 51, and 80 days after release, and 
nearly half (48.7%) of the 265 women assigned to POWER received at least 1 phone call.
The control arm received a single, 1-hour NCDOC standard-of-care STI education session 
that included basic information on STI transmission, sexual abstinence, and condom use. An 
NCDOC nurse delivered the session, provided to all women in the prison, including 
POWER participants, during the first 3 months of incarceration.
Outcome Measures
Primary outcomes were nonviral STI infections (chlamydia and gonorrhea) and sexual risk 
behaviors assessed 3 and 6 months after release. We measured STIs by nucleic acid 
amplification testing from self-collected vaginal swabs. At each interview, we asked 
participants about their sexual risk activities either prior to incarceration (baseline interview) 
or over the past 3 months (follow-up interviews).30 Behavioral risk outcomes were number 
of unprotected vaginal sexual acts without a condom, number of male sexual partners, 
partner concurrency (i.e., having vaginal intercourse with > 1 man), drug use before sexual 
intercourse, and sexual intercourse traded for money or drugs. We assessed condom use 
during vaginal intercourse over the past 3 months separately for main and nonmain male 
partners. If women did not report a main or nonmain sexual partner at baseline, we excluded 
them from analyses of condom use. Data on sexual partner concurrency and use of condoms 
with different types of partners included number of concurrent partners, beliefs regarding 
partner’s other partners, and overlapping relationships.31 We incorporated these behaviors 
into the outcome whether women engaged in unprotected vaginal intercourse in a 
nonmonogamous relationship (defined as vaginal intercourse without condoms with 
someone who was not their main partner) or with a main partner who was not monogamous.
Secondary outcomes were self-reported use of any illegal drug and employment status. 
Although the intervention was not designed specifically to target these outcomes, they are 
known to be related to sexual risk behavior and should be considered as a possible 
mechanism of the intervention. We assessed illegal drug use and employment status at each 
interview. At baseline, we asked participants about their drug use and employment status 
prior to incarceration. In the follow-up interviews, we assessed drug use over the past 3 
months.
Fogel et al. Page 5













We assessed psychosocial constructs through scales previously used with women 
prisoners.32 We assessed HIV knowledge with an 18-item questionnaire (α = 0.70)33 and 
barriers to protection with the Condom Barriers Scale (comprises total scale [α = 0.91] and 
Access [α = 0.78], Partner [α = 0.90], Physical Effect [α = 0.80], and Motivation [α = 0.68] 
subscales)34 and the 4-item Barriers To Sexual Protective Practices Scale (α = 0.76).35 
Other psychosocial measures were self-efficacy for condom use, measured by a 4-item 
condom self-efficacy questionnaire created for this study (α = 0.80); Health-Protective 
Sexual Communication Scale (α = 0.87)36; depressive symptoms, assessed with the Center 
for Epidemiological Studies Depression Scale (α = 0.89)37; and recent experiences of 
partner violence, assessed with the 30-item Index of Spouse Abuse (α = 0.92 for physical 
and 0.95 for nonphysical abuse).38 We measured feelings of power in recent relationships 
with the 8-item Power and Relationships Scale (α = 0.84).39
Statistical Analysis
We analyzed participants’ outcomes relative to their assigned study arm and regardless of 
number of sessions attended. We designed the study to have at least 80% power at a .05 
significance level to reject the null hypothesis that STI incidence rates (gonorrhea, 
chlamydia, and trichomonas) were the same for the POWER and control arms; this provided 
adequate power for other study outcomes as well. However, not all women were tested (and 
subsequently treated if positive) for trichomonas on admission, so we were unable to 
separate previous infection from infection occurring after release. Therefore, we excluded 
trichomonas as an STI outcome. Because of this, the study was underpowered to detect an 
intervention effect on the biological outcome, but power for other study outcomes was 
unaffected. We used SAS version 9.2 (SAS Institute Inc, Cary, NC) for all data analysis.
We described the sample at baseline with respect to sociodemographic variables, sexual risk 
behaviors, STIs, and psychosocial constructs. We assessed differences by assigned study 
condition by t test for continuous variables and χ2 test for dichotomous or categorical 
variables. We assessed intervention efficacy with mixed-effects models. We fit logistic 
mixed-effects models for dichotomous outcomes, negative binomial models with a log-link 
function for count outcomes (e.g., number of sexual partners and number of unprotected 
sexual acts), and linear mixed models for the continuous psychosocial outcomes.
Mixed models controlled for the baseline value of the outcome (except for biological 
outcomes, which we did not assess at the baseline interview) and included fixed effects for 
time point and intervention (treatment group). A random intercept allowed for within-
participant correlation between time 2 (3-month follow-up) and time 3 (6-month follow-up). 
We also included a time × treatment interaction to estimate a separate treatment effect for 
time 2 and time 3. We expressed intervention effects for dichotomous outcomes as adjusted 
odds ratios (AORs) and 95% confidence intervals (CIs); we expressed effects for count 
outcomes as model-estimated differences in predicted counts and 95% CIs.
RESULTS
Table 1 summarizes baseline demographic and outcome data for the 2 study arms. Women 
in the study averaged 33.8 years of age (SD = 9.21; range = 18–60). Many were White 
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(57.8%); 7 women (1.3%) were Latina. More than half (58.3%) reported being a high school 
graduate, 61.0% earned less than $18 000 per year, 58.0% received government assistance, 
and 46.8% were unemployed prior to incarceration. On average, women supported up to 3 
people with their income. More than a third of the women had never married, and the 
average number of live births was 2. Nearly 60% reported use of illegal drugs during the 30 
days before incarceration. More than a third of participants (37.6%) had previously been 
incarcerated, and the same percentage reported that their current incarceration was drug 
related.
Nearly three quarters (72.6%) of participants reported engaging in unprotected vaginal 
intercourse in a nonmonogamous relationship, 25.3% reported any condom use with main 
partners, and 28.6% reported condom use with nonmain partners. About 20% of the sample 
reported partner concurrency, and 12.9% reported trading sex. Approximately half the 
women (50.3%) reported ever having an STI, and 4.0% were diagnosed and treated for 
chlamydia or gonorrhea at admission. Women randomized to the intervention reported 
significantly greater physical and non-physical spousal abuse than control participants (P < .
01); we observed no other significant differences (Table 1).
Of 265 women assigned to the intervention arm, 179 (68%) and 158 (60%) completed the 3-
month and 6-month postrelease assessments, respectively (Figure A). The average number 
of POWER sessions attended was 5.8, and only 34 women (12.8%) did not attend any of the 
intervention sessions. Of 256 women assigned to the control arm, 155 (61%) and 142 (55%) 
completed the 3- and 6-month postrelease assessments, respectively. The 3-month follow-up 
occurred an average of 13 weeks after release (range = 9–31 weeks), and the 6-month 
follow-up occurred an average of 26 weeks after release (range = 22–43 weeks). In the 
intervention arm, the average 3-month follow-up occurred 2 weeks after the final phone call 
(range = 0–4 weeks). We observed no significant intervention differences in proportion of 
participants lost to follow-up (χ2[1] = 2.11; P = .15). Women with no follow-up data 
reported significantly more illegal drug use at baseline than did those with follow-up data; 
the groups had no other baseline differences in demographics or study outcomes.
Sexual Risk Behaviors
Tables 2 and 3 summarize intervention effects on sexual risk behaviors measured at 3 and 6 
months after release. Table 2 presents the results of logistic mixed models for dichotomous 
outcomes. At 6 months after release, POWER participants had 43% lower odds of reporting 
unprotected vaginal intercourse outside of monogamous relationships (AOR = 0.57; 95% CI 
= 0.35, 0.92) and more than twice the odds of condom use during vaginal intercourse with 
their main male partner (AOR = 2.06; 95% CI = 1.14, 3.72) relative to control participants. 
The intervention exerted no significant effects on the other dichotomous sexual risk 
behavior outcomes: condom use with nonmain male partner, partner concurrency, drug use 
before sexual intercourse, and trading sex. Likewise, we found no significant intervention 
effect on incident nonviral STIs.
Table 3 presents the results of negative binomial mixed-effects models on count outcomes. 
The intervention had no statistically significant effects, but the effect on number of male 
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sexual partners approached significance: POWER participants reported fewer male sexual 
partners at 3 and 6 months after release (P = .1 and .11, respectively).
Psychosocial Constructs
The intervention had several significant effects on psychosocial constructs (Table 4). 
POWER participants at 3 months after release reported significantly more HIV knowledge 
(b = 0.71; P < .01) and health-protective communication (b = 1.04; P < .05), fewer 
motivational barriers to condom use (b = −0.13; P < .05), and less physical spousal abuse (b 
= −2.64; P < .05) than did control participants.
At 6 months after release, POWER participants continued to report greater HIV knowledge 
(b = 0.76; P < .01) and fewer motivational barriers to condom use (b = −0.20; P < .01) than 
did women in the control group. POWER participants also reported significantly fewer 
partner barriers and physical effect barriers to condoms and greater tangible social support at 
the 6-month follow-up.
DISCUSSION
POWER provides an evidence-based curriculum adapted to the specific needs of 
incarcerated women, thereby addressing a key gap in the HIV–STI prevention portfolio for 
women in prison.21 In addition, POWER provides important resources for reentry and the 
transition of women back into their communities of origin.40 These include setting goals for 
reentry, finding employment and housing, resume writing, job interviewing, and disclosure 
of incarceration status.
At 6 months after release from prison, POWER participants reported a significant reduction 
in unprotected vaginal intercourse outside of a monogamous relationship and significantly 
greater condom use with main male sexual partners than did control participants. Although 
not statistically significant, POWER participants reported a reduction in number of male 
sexual partners at 3 months after release. We also observed favorable changes in 
psychosocial constructs, including significant increases in HIV knowledge, health-protective 
communication, and tangible social support and significant reductions in condom use 
barriers and spousal abuse. It is important to acknowledge that these significant changes in 
behaviors occurred after women were released from prison and during their reentry into their 
communities. POWER participants’ baseline levels of depression, sexual network risk, and 
number of stressors were similar to those of control group participants; thus the detection of 
significant intervention effects is remarkable because many of these women returned to 
high-risk sexual partnerships and risky sexual and substance use situations after release.
The original SAFE intervention significantly reduced unprotected vaginal intercourse with 
male partners and number of sexual partners, as well as incident nonviral STIs, including 
chlamydia and gonorrhea infections, among women in public health clinics.23,24 The 
POWER intervention, adapted to address the HIV–STI prevention needs of incarcerated 
women and delivered to women while in prison, was also efficacious in reducing sexual risk 
behaviors. However, there are plausible reasons why our study did not replicate SAFE’s 
intervention effects on STI outcomes.
Fogel et al. Page 8













The samples of the SAFE and POWER trials differed in important aspects. SAFE was 
evaluated among minority women in public health clinics with diagnosed nonviral STIs 
(gonorrhea, syphilis, and chlamydia).23 By contrast, only 4% of the incarcerated women 
enrolled in POWER were diagnosed with nonviral STIs (chlamydia or gonorrhea) at prison 
intake. POWER was statistically powered to detect intervention effects on nonviral STIs 
including trichomonas, but issues with trichomonas reporting by the North Carolina 
Correctional Institute for Women barred our use of that outcome and underpowered the 
study for the STI outcome. Finally, the SAFE study conducted assessments at 12 and 24 
months after the intervention, providing a lengthy follow-up period for women to engage in 
sexual risk behaviors leading to detectable incident STIs. By contrast, we conducted shorter 
follow-up assessments (3 and 6 months after release) because of constraints in tracking 
women after their release from prison.
Limitations
Retention of participants at follow-up assessments was low, thereby reducing power to 
detect significant intervention effects. Low retention of incarcerated populations in 
intervention trials is common,41 and the women enrolled in POWER reentered communities 
throughout North Carolina, making tracking and retention particularly difficult. 
Furthermore, women who reported more illegal drug use at baseline were more likely to be 
lost to follow-up, minimizing the intervention’s potential impact on drug users. Presumably, 
the women who had less stability upon release were those unable to be contacted for follow-
up; 97% of those interviewed at 3 months after release reported stable housing.
Another methodological limitation was that the single-session control intervention focused 
on STI prevention, rather than serving as a true placebo to guard against Hawthorne effects. 
Future studies would benefit from inclusion of a time-equivalent comparison condition 
focusing on other health-related topics. In addition, the concurrent nature of the intervention 
and control conditions in the prison increased the potential for cross-contamination. 
However, in light of the closed nature of the POWER sessions, the advantages of 
randomizing each participant outweighed the risk of cross-contamination bias. Finally, the 
trial findings may not generalize to women incarcerated in large urban areas or other regions 
of the United States.
Conclusions
Our study demonstrated that a multiple-session HIV–STI prevention intervention adapted 
for and delivered to women in prison can significantly reduce sexual risk behaviors and 
increase protective behaviors after reentry into the community. Although POWER was 
developed for HIV-negative women, it could be adapted to develop behavioral interventions 
to meet the unique HIV–STI prevention, care, and treatment needs of the thousands of HIV-
positive women who are released from correctional facilities annually.8
Prisons provide an opportunity to deliver behavioral interventions to a population at high 
risk of acquiring or transmitting HIV and STIs.27 POWER may be an important component 
of a comprehensive portfolio of services (e.g., substance use and mental health treatment, 
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housing assistance, and intimate partner violence prevention) to meet the complex needs of 
women involved in the criminal justice system.
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TABLE 1
Demographic and Other Baseline Characteristics of Intervention and Control Groups of Incarcerated Women: 




Mean ±SD or No. (%)
Control (n = 256),
Mean ±SD or No. (%)
t Test or
χ2 Test (P)
Age at baseline visit, y 34.2 ±9.20 33.4 ±9.23 1.06 (.29)
Latina ethnicity 6 (2.0) 1 (0.4) 3.45 (.06)
Race 6.78 (.24)
    White 143 (54.0) 158 (61.7)
    Black/African American 95 (35.8) 82 (32.0)
    Asian 1 (0.3) 0 (0)
    Native American 5 (1.8) 5 (2.0)
    Multiracial 12 (4.5) 6 (2.3)
    Other 8 (3.0) 3 (1.2)
    Unknown/not reported 1 (0.3) 2 (0.8)
High school graduate 159 (60.0) 145 (56.6) 0.60 (.44)
Income < $18 000/y 159 (60.0) 159 (62.1) 0.24 (.62)
People supported by income, no. 2.7 ±1.57 2.7 ±1.57 0.17 (.86)
Never married 102 (38.5) 87 (34.0) 5.64 (.46)
Receive government assistance (welfare, food stamps) 149 (56.2) 153 (59.8) 0.67 (.41)
Unemployed before incarceration 115 (43.4) 129 (50.4) 2.56 (.11)
Births, no. 2.3 ±1.42 2.4 ±1.39 1.14 (.25)
Children in household, no. 1.2 ±1.44 1.4 ±1.49 1.10 (.27)
Alcohol use in 30 d before incarceration 169 (63.8) 145 (56.6) 2.77 (.1)
Drug use (not including alcohol or marijuana) in 30 d before incarceration 157 (59.4) 147 (57.4) 0.18 (.67)
Incarceration history
    Previously incarcerated 95 (35.8) 101 (39.5) 0.72 (.4)
    Previous times in prison, no. 2.2 ±1.84 2.5 ±2.56 1.04 (.23)
    Previous times in jail, no. 6.9 ±7.00 7.6 ±8.47 0.73 (.47)
    Current offense drug-related 104 (39.3) 92 (35.9) 0.61 (.44)
Sexual risk behaviors (past 3 mo)
    Unprotected vaginal intercourse outside of monogamous relationship 194 (73.2) 184 (71.9) 0.01 (.9)
    Condom use during vaginal intercourse with main male partnera 64 (24.1) 68 (26.6) 0.68 (.41)
    Condom use during vaginal intercourse with nonmain male partnerb 15 (31.3) 11 (25.6) 0.36 (.55)
    Partner concurrencyc 54 (20.4) 48 (18.8) 0.24 (.62)
    Traded sex 33 (12.5) 34 (13.3) 0.20 (.5)
    Times traded sex (among those who traded), no. 6.9 ± 22.4 4.2 ±17.2 –1.15 (.25)
    Used drugs before sexual intercourse 123 (46.4) 101 (39.5) 2.59 (.11)
    Unprotected vaginal intercourse acts, no. 13.8 ±19.6 14.6 ±18.6 0.46 (.65)
    Male sexual partners, no. 3.3 ±13.3 2.1 ±6.9 –1.26 (.21)
Sexually transmitted infections
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Characteristic
POWER (n= 265),
Mean ±SD or No. (%)
Control (n = 256),
Mean ±SD or No. (%)
t Test or
χ2 Test (P)
    Self-reported ever had STI 140 (52.8) 122 (47.7) 1.51 (.22)
    Laboratory diagnosed chlamydia or gonorrhead 10 (3.8) 11 (4.3) 0.09 (.83)
HIV knowledge 14.1 ±2.44 14.1 ±2.50 −0.22 (.83)
Condom barriers 2.3 ±0.43 2.3 ±0.50 −1.04 (.3)
    Access 2.0 ±0.40 2.0 ±0.45 −0.02 (.99)
    Partner 2.4 ±0.71 2.3 ±0.72 −1.77 (.08)
    Effect 2.5 ±0.64 2.5 ±0.70 −0.19 (.85)
    Motivation 2.4 ±0.53 2.3 ±0.58 −0.85 (.4)
Condom self-efficacy 4.4 ±0.72 4.4 ±0.76 0.44 (.66)
Barriers to sexual protective practices 7.9 ±2.21 7.8 ±2.16 −0.24 (.81)
Health-Protective Communication Scale 39.4 ±5.50 39.9 ±5.58 0.93 (.35)
Depression 168 (63.4) 177 (69.1) 1.92 (.17)
Social support 4.1 ±0.93 4.2 ±0.80 1.38 (.17)
Emotional/informational support 4.0 ±1.03 4.1 ±0.87 1.47 (.14)
Tangible support 4.1 ±1.07 4.1 ±0.95 1.11 (.27)
Affectionate support 4.3 ±0.97 4.4 ±0.82 0.94 (.35)
Positive social interaction 4.1 ±0.99 4.2 ±0.83 1.17 (.24)
Social network risk 3.6 ±0.38 3.7 ±0.35 1.47 (.14)
Stressors, no. 6.9 ±4.68 6.2 ±4.43 −1.78 (.08)
Physical Index of Spouse Abuse 11.2 ±17.20 7.5 (±4.21 −2.7 (.007)
Nonphysical Index of Spouse Abuse 15.3 ±20.63 10.3 ±15.79 −3.1 (.002)
Power and attitudes in relationships 3.1 ±0.37 3.1 ±0.36 −0.5 (.63)
Note. POWER = Providing Opportunities for Women’s Empowerment, Risk-Reduction, and Relationships; STI = sexually transmitted infection.
a
Among participants who reported vaginal intercourse with main partner (n = 437; 225 intervention and 212 control).
b
Among participants who reported vaginal intercourse with nonmain partner (n = 91; 48 intervention and 43 control).
c
Defined as having more than 1 male sexual partner during any 1 week out of the 4 weeks prior to incarceration.
d
Two POWER participants did not provide data on baseline STIs.
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